Although previous studies showed the significant associations of TET1 and TET2 expression with AML prognosis [14, 15], herein, we only observed that TET3 expression acted as an independent prognostic factor in AML, and could be overcame by HSCT. This evidence concerns the gene TET2 and acute myeloid leukemia.